Answer:
The answer is below
Step-by-step explanation:
Possible major tensions that exist when a pharmaceutical firm forms an alliance with a biotechnology firm are the following amongst others:
1. There is high competition from other alliances between different pharmaceutical and biotechnological firms:
In recent times, several pharmaceutical and biotechnological firms are establishing partnerships with a high probability of success, in the development of drugs and marketing. This has led to more competition and which made firms to be under immense pressure to formulate new products.
2. More public attention of the business methods and profits by the government:
Many policies and regulations regarding the healthcare sectors are designed to checkmate corrupt practices in the health industry. Thus, such alliances need to accept such regulations and operate. Otherwise, this may result in the cancellation of the permission of the operation.
3. The interdependence of the firms involved:
Both firms might find it difficult to operate most specifically at the beginning, as there will be little tension when it comes to management decisions and operation.